Specializing in High-Value Products such as Corticosteroids and Ticagrelor Intermediates.
THREE MAJOR CORE PRODUCT AREAS. | |||
Corticosteroid Intermediates | Absolute Advantage Area – Providing key intermediates such as hydrocortisone, betamethasone, dexamethasone, prednisolone, etc., with mature processes, stable quality, and sufficient production capacity. The technical research and development, as well as reserves, for high-end hormone products like desogestrel, have been completed. | ||
Diabetes Medication Intermediates | Huge Market Demand – Stable supply of intermediates for various mainstream oral hypoglycemic drugs such as glimepiride and empagliflozin, serving the vast global diabetes medication market and meeting the growing clinical demand. | ||
High-End Specialty APIs | Broad Prospects – Actively expanding the product pipeline, including new-generation drug intermediates such as Frelanaz (veterinary innovative drug), Tigagrelor (antithrombotic drug), and Enzalutamide (anti-prostate cancer drug). | ||